USANA Health Sciences, Inc. was honored by Utah Business magazine as a “Best Company to Work For” 2022. This award is based upon anonymous employee surveys, which rank companies on a number of factors like flexibility, pay equity, management and more.
Rise Bar manufactures high-quality protein bars with clean and simple ingredients while Oola is an emerging direct selling company that focuses on helping customers design a personal development framework that creates balance, growth and purpose.
A new study is quantifying the direct selling industry’s impact on the economy of Utah, a measurement that has never before been documented. In An Economic Analysis of Utah’s Direct Selling Industry, a 24-page white paper authored by Senior Research Economist Levi Pace for the Kem C. Gardner Policy Institute at the University of Utah, Pace details 19 months of data collection and surveys.
USANA Health Sciences, Inc. announced financial results for its fiscal third quarter that it described as “modestly ahead” of the previous outlook provided in mid-September.
In a new collaboration between Dr. Mehmet Oz, MD, Beijing University of Chinese Medicine President Anlong Xu, Ph.D., and USANA Health Sciences, Eastern and Western medicine meld together in the holistic health guidebook Yin Yang You.
USANA Health Sciences, Inc. announced preliminary third quarter results, including 2021 net sales expected to reach between $265 to $275 million, a decrease from the prior year period’s $299 million.
USANA Health Sciences, Inc., along with its Chinese subsidiary, BabyCare, Ltd., announced a research collaboration agreement with the Beijing University of Chinese Medicine (BUCM). Through this partnership, USANA and BUCM will share research to unite modern nutritional science with Traditional Chinese Medicine and potentially improve the health and wellness of people around the world. Together, […]
USANA Health Sciences, Inc. released its Q1 2021 financial reports. The company’s first quarter net sales increased 15.5% year-over-year, totaling $308 million, and a diluted EPS increase of 17.9% year-over-year to $1.45. There was also a repurchase of 721,000 shares for $69.5 million during Q1. Active customers during the quarter increased 7.7% over the same […]
Direct selling stocks continue to outperform the Dow Jones Industrial Average (DJIA) amid the current pandemic environment*. Insights from investment banking and business development firm Transformation Capital show that both large-cap and small-cap direct selling stocks have continued to exceed financial expectations since early March, when the coronavirus began to have an economic impact on […]
USANA Health Sciences, Inc. announced $266.6 million in net sales for first quarter ended March 28, 2020, down 2.3 percent versus the prior-year quarter. “During this unprecedented period, we extend our gratitude to medical personnel, health officials, government leaders and volunteers around the world who are working tirelessly to respond to the COVID-19 pandemic,” said […]
USANA Health Sciences, Inc. (NYSE: USNA) yesterday announced financial results for its fiscal fourth quarter and full year ended December 28, 2019. Fourth quarter 2019 net sales were $271.3 million, compared with $299.0 million in the prior-year period. The company’s total number of active Customers at the end of the fourth quarter was 586,000, compared […]
USANA Health Sciences, Inc. (NYSE: USNA) yesterday announced financial results for its fiscal fourth quarter and full year ended December 28, 2019. Fourth quarter 2019 net sales were $271.3 million, compared with $299.0 million in the prior-year period. The company’s total number of active Customers at the end of the fourth quarter was 586,000, compared […]